Systemic treatment of xenografts with vaccinia virus GLV-1h68 reveals the immunologic facet of oncolytic therapy

BACKGROUND: GLV-1h68 is an attenuated recombinant vaccinia virus (VACV) that selectively colonizes established human xenografts inducing their complete regression. RESULTS: Here, we explored xenograft/VACV/host interactions in vivo adopting organism-specific expression arrays and tumor cell/VACV in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Worschech, Andrea, Chen, Nanhai, Yu, Yong A, Zhang, Qian, Pos, Zoltan, Weibel, Stephanie, Raab, Viktoria, Sabatino, Marianna, Monaco, Alessandro, Liu, Hui, Monsurró, Vladia, Buller, R Mark, Stroncek, David F, Wang, Ena, Szalay, Aladar A, Marincola, Francesco M
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2009
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2713268/
https://ncbi.nlm.nih.gov/pubmed/19583830
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2164-10-301
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados